Shopping Cart
- Remove All
- Your shopping cart is currently empty
OSIP-486823(CP248) is a novel and potent microtubule disruptor with affinity for both protein kinase G (PKG) and microtubules.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $566 | 6-8 weeks | |
5 mg | $1,180 | 6-8 weeks | |
10 mg | $1,620 | 6-8 weeks | |
25 mg | $2,390 | 6-8 weeks | |
50 mg | $3,250 | 6-8 weeks |
Description | OSIP-486823(CP248) is a novel and potent microtubule disruptor with affinity for both protein kinase G (PKG) and microtubules. |
Targets&IC50 | SW480:0.1 μM |
In vitro | In SW480 human colon cancer cells, OSIP-486823 inhibits growth and induces apoptosis with an IC50 of 0.1 μM. OSIP-486823, a member of a new class of drugs known as selective apoptotic antineoplastic drugs targeting cyclic guanosine 3′,5′-monophosphate phosphodiesterases (cGMP-PDE), causes depolymerization of microtubules in interphase cells, inhibits spindle formation in mitotic cells, and induces multinucleated cells. Furthermore, OSIP-486823 disrupts microtubule polymerization, perturbs mitotic spindle function, and arrests cells in mitosis in human glioma cells [1]. |
Alias | CP248 |
Molecular Weight | 473.54 |
Formula | C29H28FNO4 |
Cas No. | 200803-37-8 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.